It was announced today that Dr Kiran Patil, Principal Investigator at the MRC Toxicology Unit, has been awarded €150,000 from the European Research Council (ERC) to develop novel live biotherapeutics for boosting cancer therapy. In this ERC funded project, Kiran’s group will use their expertise in microbial co-evolution to...